These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9075504)

  • 1. User-friendly weight-based heparin protocol for initial infusion.
    Hanish LR
    Am J Health Syst Pharm; 1997 Mar; 54(6):699-700. PubMed ID: 9075504
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin dosing.
    Farnsworth TL
    S D J Med; 1995 Nov; 48(11):386-7. PubMed ID: 8525352
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight-based heparin dosing: clinical response and resource utilization.
    Lackie CL; Luzier AB; Donovan JA; Feras HI; Forrest A
    Clin Ther; 1998; 20(4):699-710. PubMed ID: 9737830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 6. Contamination of intravenous heparin infusions.
    Cheesbrough JS; Catlow R
    J Hosp Infect; 1999 Nov; 43(3):247-8. PubMed ID: 10582194
    [No Abstract]   [Full Text] [Related]  

  • 7. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method to predict patients' intravenous heparin dose requirements.
    Reilly BM; Raschke RA
    J Gen Intern Med; 1996 Mar; 11(3):168-73. PubMed ID: 8667094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.
    Hosch LM; Breedlove EY; Scono LE; Knoderer CA
    Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical considerations of heparinization.
    Cushinotto NM
    J Am Acad Nurse Pract; 1997 Jun; 9(6):273-6. PubMed ID: 9274247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-directed tissue plasminogen activator infusion and concurrent systemic anticoagulation with heparin to treat portal vein thrombosis post orthoptic liver transplantation.
    Gill P; Oniscu GC; Mayer DA; Mirza DF; Olliff S
    Transplantation; 2009 Aug; 88(4):595-6. PubMed ID: 19696645
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparins].
    Marbet GA
    Ther Umsch; 2003 Jan; 60(1):10-3. PubMed ID: 12638471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic Therapy Strategy for Cancer-Associated Ischemic Stroke: A Case Series of 26 Patients.
    Naito H; Nezu T; Hosomi N; Aoki S; Ueno H; Ochi K; Maruyama H
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e206-e211. PubMed ID: 29779882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin therapy: current regimens and principles of monitoring.
    Berry BR; Nantel S
    Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated partial thromboplastin times from venipuncture versus central venous catheter specimens in adults receiving continuous heparin infusions.
    Dailey MS; Berger B; Dabu F
    Crit Care Nurse; 2014 Oct; 34(5):27-42. PubMed ID: 25274762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults.
    Hohner EM; Kruer RM; Gilmore VT; Streiff M; Gibbs H
    J Crit Care; 2015 Apr; 30(2):395-9. PubMed ID: 25534987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
    Hirsh J
    Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.